IP Library › Assignment 028347/0088
Patent Assignment
Reel/Frame 028347/0088

Release of Security Interest

Recorded: 2012-06-08 Pages: 14
Assignors
SPROUT CAPITAL IX, L.P.
Executed: 2012-06-06
SPROUT ENTREPRENEURS' FUND, L.P.
Executed: 2012-06-06
INVESTOR GROWTH CAPITAL LIMITED
Executed: 2012-06-06
INVESTOR GROUP L.P.
Executed: 2012-06-06
DIONIS TRUST
Executed: 2012-06-06
GRANT GUND 1978 TRUST
Executed: 2012-06-06
G. ZACHARY GUND 1978 TRUST
Executed: 2012-06-06
KBL HELATHCARE, LP
Executed: 2012-06-06
KBL PARTNERSHIP, LP
Executed: 2012-06-06
SANDERLING V LIMITED PARTNERSHIP
Executed: 2012-06-06
Assignee
ISTA PHARMACEUTICALS, INC.
50 TECHNOLOGY DRIVE, IRVINE, CALIFORNIA, 92618
Covered Properties (12)
Enzyme-Orthokeratology
Patent: 5,270,051 →
Application: 07/776,211 →
Enzyme-Orthokeratology
Patent: 5,626,865 →
Application: 08/211,749 →
A Method for Accelerating Clearance of Hemorrhagic Blood from the Vireous Humor with Hyaluronidase
Patent: 5,866,120 →
Application: 08/561,636 →
Enzyme-Orthokeratology
Patent: 5,788,957 →
Application: 08/712,967 →
Enzyme-Orthokeratology
Patent: 6,132,735 →
Application: 08/932,974 →
Method for Accelerating Clearance of Hemorrhagic Blood from the Vitreous Body with Hyaluronidase
Patent: 6,039,943 →
Application: 09/139,282 →
Use of Hyaluronidase in the Manufacture of an Ophthalmic Preparation for Liquefying Vitreous Humor in the Treatment of Eye Disorders
Patent: 6,610,292 →
Application: 09/444,003 →
Publication: US 2002/0164316
Hyaluronidase Preparation for Ophthalmic Administration and Enzymatic Methods for Accelerating Clearance of Hemorrhagic Blood from the Vireous Body of the Eye
Patent: 6,551,590 →
Application: 09/453,012 →
Publication: US 2002/0071837
Use of Corneal Hardening Agents in Enzymeorthokeratology
Patent: 6,537,545 →
Application: 09/656,849 →
Biochemical Methods That Eliminate Corneal Scars, Opacification and Haze
Patent: 6,737,075 →
Application: 09/975,039 →
Publication: US 2002/0119141
Method of Stabilizing Hyaluronidase with Annexin Ii
Patent: 7,115,408 →
Application: 10/139,139 →
Compositions and Methods for the Induction of Retinal Detachments
Patent: 7,141,610 →
Application: 10/160,135 →
Publication: US 2003/0165486
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 15, 2013
From: ISTA PHARMACEUTICALS, LLC
To: BAUSCH & LOMB PHARMA HOLDINGS CORP.
Reel/Frame 031019/0937 →
Security Agreement Nov 1, 2013
From: BAUSCH & LOMB PHARMA HOLDINGS CORP.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031533/0859 →
Notice of Succession of Agency Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Security Interest Jul 19, 2017
From: BAUSCH & LOMB PHARMA HOLDINGS CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043046/0030 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Merger Dec 4, 2019
From: RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; B&L FINANCIAL HOLDINGS CORP.; BAUSCH & LOMB CHINA, INC.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 051177/0793 →
Release of Security Interest in Specified Patents (Reel/Frame 045444/0299) Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC
Reel/Frame 061779/0001 →
Release of Security Interest in Specified Patents (Reel/Frame 031533/0859) Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061778/0306 →
Release of Security Interest in Specified Patents (Reel/Frame 034749/0689) Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; UNIVERSITY OF ROCHESTER
Reel/Frame 061778/0146 →
Omnibus Patent Security Release Agreement (Reel/Frame 043046/0030) Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061874/0179 →
Omnibus Patent Security Release Agreement (Reel/Frame 045444/0634) Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
Omnibus Patent Security Release Agreement (Reel/Frame 048556/0758) Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH COMPANIES INC.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0484 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
Reel/Frame 073637/0126 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
Reel/Frame 073637/0001 →